Save time and get answers to complex questions with AI chat
Quartette side effects?Patent expiration eu dabrafenib?Guselkumab patent expiration?Bortezomib market france?Pramlintide fda approval date?
See the DrugPatentWatch profile for Pazopanib
Votrient (pazopanib) received FDA approval on October 19, 2009 for the treatment of advanced renal cell carcinoma (RCC) [1].
At launch, Votrient was approved for advanced renal cell carcinoma [1].
DrugPatentWatch.com tracks drug regulatory and patent-related timelines and can be used to cross-check key dates like FDA approval [1]. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Pazopanib :